Herbal medicines in the management of urolithiasis: Alternative or complementary?

Planta Medica

Volumn 75, Issue 10, 2009, Pages 1095-1103

  Butterweck, Veronika ^a   Khan, Saeed R ^b  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Alternative medicine; Calcium oxalate; Citrates; Complementary medicine; Kidney stones; Nephrolithiasis; Oxalates; Plant extracts; Urolithiasis

Indexed keywords

ADENOSINE A1 RECEPTOR; CITRATE POTASSIUM; DOLICHOS BIFLORUS EXTRACT; FLAVONOID; HERBACEOUS AGENT; HERNIARIA HIRSUTA EXTRACT; HIBISCUS SABDARIFFA EXTRACT; PHYLLANTUS NIRURI EXTRACT; PLANT EXTRACT; QUERCUS SALICINA EXTRACT; SAMBUCUS NIGRA EXTRACT; SOLIDAGO VIRGAUREA EXTRACT; TAKUSHA; UNCLASSIFIED DRUG; VIGNA UNGUICULATA EXTRACT;

ALTERNATIVE MEDICINE; ANDROGRAPHIS PANICULATA; ANTIOXIDANT ACTIVITY; ARCTOSTAPHYLOS UVA URSI; CALCIUM OXALATE STONE; CALCIUM STONE; CARYOPHYLLACEAE; CLINICAL TRIAL; COWPEA; DIET RESTRICTION; DIURETIC ACTIVITY; DOLICHOS BIFLORUS; DRUG EFFECT; EQUISETUM; EQUISETUM ARVENSE; EXTRACORPOREAL LITHOTRIPSY; FLUID INTAKE; FRUIT JUICE; HEMATOMA; HEMATURIA; HERBAL MEDICINE; HERNIARIA HIRSUTA; HUMAN; KIDNEY HEMORRHAGE; MEDICINAL PLANT; NEPHROLITHIASIS; NONHUMAN; OAK; ORTHOSIPHON; ORTHOSIPHON GRANDIFLORUS; PATHOPHYSIOLOGY; PHYLLANTUS NIRURI; PLANT SEED; PYURIA; QUERCUS SALICINA; RECURRENT DISEASE; REVIEW; RISK FACTOR; STONE FORMATION; URETEROSCOPY; URINARY TRACT INFECTION; UROLITHIASIS; LITHOTRIPSY;

HERBAL MEDICINE; HUMANS; LITHOTRIPSY; UROLITHIASIS;

EID: 70350787136     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0029-1185719     Document Type: Review

References (105)

1. Moe OW. Kidney stones: pathophysiology and medical management. Lancet 2006; 367: 333-344
2. Tiselius HG. Epidemiology and medical management of stone disease. BJU Int 2003; 91: 758-767
3. Devuyst O, Pirson Y. Genetics of hypercalciuric stone forming diseases. Kidney Int 2007; 72: 1065-1072
4. Knoll T. Stone disease. Eur Urol Suppl 2007; 6: 717-722
5. Worcester EM, Coe FL. Nephrolithiasis. Prim Care 2008; 35: 369-391
6. Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA 2005; 293: 455-462
7. Obligado SH, Goldfarb DS. The association of nephrolithiasis with hypertension and obesity: a review. Am J Hypertens 2008; 21: 257-264
8. Coll DM, Varanelli MJ, Smith RC. Relationship of spontaneous passage of ureteral calculi to stone size and location as revealed by unenhanced helical CT. AJR Am J Roentgenol 2002; 178: 101-103
9. Nabi G, Downey P, Keeley F, Watson G, McClinton S. Extra-corporeal shock wave lithotripsy (ESWL) versus ureteroscopic management for ureteric calculi. Cochrane Database Syst Rev 2007: CD006029
10. Tombolini P, Ruoppolo M, Bellorofonte C, Zaatar C, Follini M. Lithotripsy in the treatment of urinary lithiasis. J Nephrol 2000; 13 (Suppl. 3): S71-S82
11. Dellabella M, Milanese G, Muzzonigro G. Medical-expulsive therapy for distal ureterolithiasis: randomized prospective study on role of corticosteroids used in combination with tamsulosin-simplified treatment regimen and health-related quality of life. Urology 2005; 66: 712-715
12. Asplin J, Parks J, Lingeman J, Kahnoski R, Mardis H, Lacey S, Goldfarb D, Grasso M, Coe F. Supersaturation and stone composition in a network of dispersed treatment sites. J Urol 1998; 159: 1821-1825
13. Daudon M, Lacour B, Jungers P. High prevalence of uric acid calculi in diabetic stone formers. Nephrol Dial Transplant 2005; 20: 468-469
14. Park S, Pearle MS. Pathophysiology andmanagement of calcium stones. Urol Clin North Am 2007; 34: 323-334
15. Miller NL, Evan AP, Lingeman JE. Pathogenesis of renal calculi. Urol Clin North Am 2007; 34: 295-313
16. Khan SR. Renal tubular damage/dysfunction: key to the formation of kidney stones. Urol Res 2006; 34: 86-91
17. Khan SR, Kok DJ. Modulators of urinary stone formation. Front Biosci 2004; 9: 1450-1482
18. Fasano JM, Khan SR. Intratubular crystallization of calcium oxalate in the presence of membrane vesicles: an in vitro study. Kidney Int 2001; 59: 169-178
19. Khan SR, Glenton PA, Backov R, Talham DR. Presence of lipids in urine, crystals and stones: implications for the formation of kidney stones. Kidney Int 2002; 62: 2062-2072
20. Silberstein J, Lakin CM, Kellogg Parsons J. Shock wave lithotripsy and renal hemorrhage. Rev Urol 2008; 10: 236-241
21. Hassan I, Zietlow SP. Acute pancreatitis after extracorporeal shock wave lithotripsy for a renal calculus. Urology 2002; 60: 1111
22. Rashid P, Steele D, Hunt J. Splenic rupture after extracorporeal shock wave lithotripsy. J Urol 1996; 156: 1756-1757
23. Rubin JI, Arger PH, Pollack HM, Banner MP, Coleman BG, Mintz MC, Van Arsdalen KN. Kidney changes after extracorporeal shock wave lithotripsy: CT evaluation. Radiology 1987; 162: 21-24
24. Krambeck AE, GettmanMT, Rohlinger AL, Lohse CM, Patterson DE, Segura JW. Diabetes mellitus and hypertension associated with shock wave lithotripsy of renal and proximal ureteral stones at 19 years of followup. J Urol 2006; 175: 1742-1747
25. Pearle MS, Nadler R, Bercowsky E, Chen C, Dunn M, Figenshau RS, Hoenig DM, McDougall EM, Mutz J, Nakada SY, Shalhav AL, Sundaram C, Wolf Jr JS, Clayman RV. Prospective randomized trial comparing shock wave lithotripsy and ureteroscopy for management of distal ureteral calculi. J Urol 2001; 166: 1255-1260
26. Fellstrom B, Danielson BG, Karlstrom B, Lithell H, Ljunghall S, Vessby B, Wide L. Effects of high intake of dietary animal protein on mineral metabolism and urinary supersaturation of calcium oxalate in renal stone formers. Br J Urol 1984; 56: 263-269
27. Laerum E, Larsen S. Thiazide prophylaxis of urolithiasis. A double-blind study in general practice. Acta Med Scand 1984; 215: 383-389
28. Mattle D, Hess B. Preventive treatment of nephrolithiasis with alkali citrate - a critical review. Urol Res 2005; 33: 73-79
29. Achilles W. In vitro crystallisation systems for the study of urinary stone formation.World J Urol 1997; 15: 244-251
30. Verkoelen CF, van der Boom BG, Schroder FH, Romijn JC. Cell cultures and nephrolithiasis.World J Urol 1997; 15: 229-235
31. Atmani F, Khan SR. Effects of an extract from Herniaria hirsuta on calcium oxalate crystallization in vitro. BJU Int 2000; 85: 621-625
32. Atmani F, Farell G, Lieske JC. Extract from Herniaria hirsuta coats calcium oxalate monohydrate crystals and blocks their adhesion to renal epithelial cells. J Urol 2004; 172: 1510-1514
33. Barros ME, Schor N, Boim MA. Effects of an aqueous extract from Phyllantus niruri on calcium oxalate crystallization in vitro. Urol Res 2003; 30: 374-379
34. Campos AH, Schor N. Phyllanthus niruri inhibits calcium oxalate endocytosis by renal tubular cells: its role in urolithiasis. Nephron 1999; 81: 393-397
35. Garimella TS, Jolly CI, Narayanan S. In vitro studies on antilithiatic activity of seeds of Dolichos biflorus Linn. and rhizomes of Bergenia ligulata Wall. Phytother Res 2001; 15: 351-355
36. Chen YC, Ho CY, Chen LD, Hsu SF, ChenWC.Wu-Ling-San formula inhibits the crystallization of calcium oxalate in vitro. Am J Chin Med 2007; 35: 533-541
37. Koide T, Yamaguchi S, Utsunomiya M, Yoshioka T, Sugiyama K. The inhibitory effect of kampou extracts on in vitro calcium oxalate crystallization and in vivo stone formation in an animal model. Int J Urol 1995; 2: 81-86
38. Oussama A, Touhami M, Mbarki M. In vitro and in vivo study of effect of lemon juice on urinary lithogenesis. Arch Esp Urol 2005; 58: 1087-1092
39. Kulaksizoglu S, Sofikerim M, Cevik C. In vitro effect of lemon and orange juices on calcium oxalate crystallization. Int Urol Nephrol 2008; 40: 589-594
40. Hackett RL, Shevock PN, Khan SR. Cell injury associated calcium oxalate crystalluria. J Urol 1990; 144: 1535-1538
41. Khan SR, Shevock PN, Hackett RL. Membrane-associated crystallization of calcium oxalate in vitro. Calcif Tissue Int 1990; 46: 116-120
42. Moriyama MT, Miyazawa K, Noda K, Oka M, Tanaka M, Suzuki K. Reduction in oxalate-induced renal tubular epithelial cell injury by an extract from Quercus salicina Blume/Quercus stenophylla Makino. Urol Res 2007; 35: 295-300
43. Jeong BC, Kim BS, Kim JI, Kim HH. Effects of green tea on urinary stone formation: an in vivo and in vitro study. J Endourol 2006; 20: 356-361
44. Khan SR. Animal models of kidney stone formation: an analysis.World J Urol 1997; 15: 236-243
45. Yasui T, Fujita K, Sato M, Sugimoto M, Iguchi M, Nomura S, Kohri K. The effect of takusha, a kampo medicine, on renal stone formation and osteopontin expression in a rat urolithiasis model. Urol Res 1999; 27: 194-199
46. Buffington CA, Blaisdell JL, Komatsu Y, Kawase K. Effects of choreito and takushya consumption on in vitro and in vivo struvite solubility in cat urine. Am J Vet Res 1997; 58: 150-152
47. Buffington CA, Blaisdell JL, Kawase K, Komatsu Y. Effects of choreito consumption on urine variables of healthy cats fed a magnesium-supplemented commercial diet. Am J Vet Res 1997; 58: 146-149
48. Atmani F, Slimani Y, Mimouni M, Aziz M, Hacht B, Ziyyat A. Effect of aqueous extract from Herniaria hirsuta L. on experimentally nephrolithiasic rats. J Ethnopharmacol 2004; 95: 87-93
49. Atmani F, Slimani Y, Mimouni M, Hacht B. Prophylaxis of calcium oxalate stones by Herniaria hirsuta on experimentally induced nephrolithiasis in rats. BJU Int 2003; 92: 137-140
50. Grases F, Ramis M, Costa-Bauza A, March JG. Effect of Herniaria hirsute and Agropyron repens on calcium oxalate urolithiasis risk in rats. J Ethnopharmacol 1995; 45: 211-214
51. Barros ME, Lima R, Mercuri LP, Matos JR, Schor N, Boim MA. Effect of extract of Phyllanthus niruri on crystal deposition in experimental urolithiasis. Urol Res 2006; 34: 351-357
52. Freitas AM, Schor N, Boim MA. The effect of Phyllanthus niruri on urinary inhibitors of calcium oxalate crystallization and other factors associated with renal stone formation. BJU Int 2002; 89: 829-834
53. Haleblian GE, Leitao VA, Pierre SA, Robinson MR, Albala DM, Ribeiro AA, Preminger GM. Assessment of citrate concentrations in citrus fruitbased juices and beverages: implications for management of hypocitraturic nephrolithiasis. J Endourol 2008; 22: 1359-1366
54. Grases F, Masarova L, Costa-Bauza A, March JG, Prieto R, Tur JA. Effect of "Rosa Canina" infusion and magnesium on the urinary risk factors of calcium oxalate urolithiasis. Planta Med 1992; 58: 509-512
55. Touhami M, Laroubi A, Elhabazi K, Loubna F, Zrara I, Eljahiri Y, Oussama A, Grases F, Chait A. Lemon juice has protective activity in a rat urolithiasis model. BMC Urol 2007; 7: 18
56. Minato K, Miyake Y, Fukumoto S, Yamamoto K, Kato Y, Shimomura Y, Osawa T. Lemon flavonoid, eriocitrin, suppresses exercise-induced oxidative damage in rat liver. Life Sci 2003; 72: 1609-1616
57. Yu J,Wang L, Walzem RL, Miller EG, Pike LM, Patil BS. Antioxidant activity of citrus limonoids, flavonoids, and coumarins. J Agric Food Chem 2005; 53: 2009-2014
58. Tugcu V, Kemahli E, Ozbek E, Arinci YV, Uhri M, Erturkuner P, Metin G, Seckin I, Karaca C, Ipekoglu N, Altug T, Cekmen MB, Tasci AI. Protective effect of a potent antioxidant, pomegranate juice, in the kidney of rats with nephrolithiasis induced by ethylene glycol. J Endourol 2008; 22: 2723-2731
59. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL. How often is medication taken as prescribed? A novel assessment technique. JAMA 1989; 261: 3273-3277
60. Wabner CL, Pak CY. Effect of orange juice consumption on urinary stone risk factors. J Urol 1993; 149: 1405-1408
61. Odvina CV. Comparative value of orange juice versus lemonade in reducing stone-forming risk. Clin J Am Soc Nephrol 2006; 1: 1269-1274
62. Honow R, Laube N, Schneider A, Kessler T, Hesse A. Influence of grapefruit-, orange- and apple-juice consumption on urinary variables and risk of crystallization. Br J Nutr 2003; 90: 295-300
63. Goldfarb DS, Asplin JR. Effect of grapefruit juice on urinary lithogenicity. J Urol 2001; 166: 263-267
64. Trinchieri A, Lizzano R, Bernardini P, Nicola M, Pozzoni F, Romano AL, Serrago MP, Confalanieri S. Effect of acute load of grapefruit juice on urinary excretion of citrate and urinary risk factors for renal stone formation. Dig Liver Dis 2002; 34 (Suppl. 2): S160-S163
65. Seltzer MA, Low RK, McDonald M, Shami GS, Stoller ML. Dietary manipulation with lemonade to treat hypocitraturic calcium nephrolithiasis. J Urol 1996; 156: 907-909
66. Kang DE, Sur RL, Haleblian GE, Fitzsimons NJ, Borawski KM, Preminger GM. Long-term lemonade based dietary manipulation in patients with hypocitraturic nephrolithiasis. J Urol 2007; 177: 1358-1362; discussion 62
67. Penniston KL, Steele TH, Nakada SY. Lemonade therapy increases urinary citrate and urine volumes in patients with recurrent calcium oxalate stone formation. Urology 2007; 70: 856-860
68. Gettman MT, Ogan K, Brinkley LJ, Adams-Huet B, Pak CY, Pearle MS. Effect of cranberry juice consumption on urinary stone risk factors. J Urol 2005; 174: 590-594
69. McHarg T, Rodgers A, Charlton K. Influence of cranberry juice on the urinary risk factors for calcium oxalate kidney stone formation. BJU Int 2003; 92: 765-768
70. Kessler T, Jansen B, Hesse A. Effect of blackcurrant-, cranberry- and plum juice consumption on risk factors associated with kidney stone formation. Eur J Clin Nutr 2002; 56: 1020-1023
71. Howell AB, Vorsa N, Der Marderosian A, Foo LY. Inhibition of the adherence of P-fimbriated Escherichia coli to uroepithelial-cell surfaces by proanthocyanidin extracts from cranberries. N Engl J Med 1998; 339: 1085-1086
72. Muangman V, Viseshsindh V, Ratana-Olarn K, Buadilok S. The usage of Andrographis paniculata following extracorporeal shock wave lithotripsy (ESWL). J Med Assoc Thai 1995; 78: 310-313
73. Grases F, Melero G, Costa-Bauza A, Prieto R, March JG. Urolithiasis and phytotherapy. Int Urol Nephrol 1994; 26: 507-511
74. Melzig MF. Goldenrod - a classical exponent in the urological phytotherapy. Wien MedWochenschr 2004; 154: 523-527
75. Walz B, Chrubasik S. Impact of a proprietary concentrate of Sambucus nigra L. on urinary pH. Phytother Res 2008; 22: 977-978
76. Kirdpon S, Nakorn SN, Kirdpon W. Changes in urinary chemical composition in healthy volunteers after consuming roselle (Hibiscus sabdariffa Linn.) juice. J Med Assoc Thai 1994; 77: 314-321
77. Prasongwatana V, Woottisin S, Sriboonlue P, Kukongviriyapan V. Uricosuric effect of Roselle (Hibiscus sabdariffa) in normal and renal-stone former subjects. J Ethnopharmacol 2008; 117: 491-495
78. Premgamone A, Sriboonlue P, Disatapornjaroen W, Maskasem S, Sinsupan N, Apinives C. A long-term study on the efficacy of a herbal plant, Orthosiphon grandiflorus, and sodium potassium citrate in renal calculi treatment. Southeast Asian J Trop Med Public Health 2001; 32: 654-660
79. Yuliana ND, Khatib A, Link-Struensee AM, Ijzerman AP, Rungkat-Zakaria F, Choi YH, Verpoorte R. Adenosine A1 receptor binding activity of methoxy flavonoids from Orthosiphon stamineus. Planta Med 2009; 75: 132-136
80. Modlinger PS, Welch WJ. Adenosine A1 receptor antagonists and the kidney. Curr Opin Nephrol Hypertens 2003; 12: 497-502
81. Poulsen SA, Quinn RJ. Adenosine receptors: new opportunities for future drugs. Bioorg Med Chem 1998; 6: 619-641
82. Nishiura JL, Campos AH, Boim MA, Heilberg IP, Schor N. Phyllanthus niruri normalizes elevated urinary calcium levels in calcium stone forming (CSF) patients. Urol Res 2004; 32: 362-366
83. Micali S, Sighinolfi MC, Celia A, De Stefani S, Grande M, Cicero AF, Bianchi G. Can Phyllanthus niruri affect the efficacy of extracorporeal shock wave lithotripsy for renal stones? A randomized, prospective, longterm study. J Urol 2006; 176: 1020-1022
84. Doddola S, Pasupulati H, Koganti B, Prasad KV. Evaluation of Sesbania grandiflora for antiurolithiatic and antioxidant properties. Nat Med (Tokyo) 2008; 62: 300-307
85. Soundararajan P, Mahesh R, Ramesh T, Begum VH. Effect of Aerva lanata on calcium oxalate urolithiasis in rats. Indian J Exp Biol 2006; 44: 981-986
86. Selvam R, Kalaiselvi P, Govindaraj A, Bala Murugan V, Sathish Kumar AS. Effect of A. lanata leaf extract and Vediuppu chunnam on the urinary risk factors of calcium oxalate urolithiasis during experimental hyperoxaluria. Pharmacol Res 2001; 43: 89-93
87. Karadi RV, Gadge NB, Alagawadi KR, Savadi RV. Effect of Moringa oleifera Lam. root-wood on ethylene glycol induced urolithiasis in rats. J Ethnopharmacol 2006; 105: 306-311
88. Christina AJ, Ashok K, Packialakshmi M, Tobin GC, Preethi J, Murugesh N. Antilithiatic effect of Asparagus racemosus Willd on ethylene glycol-induced lithiasis in male albinoWistar rats. Methods Find Exp Clin Pharmacol 2005; 27: 633-638
89. Christina AJ, Priya Mole M, Moorthy P. Studies on the antilithic effect of Rotula aquatica lour in male Wistar rats. Methods Find Exp Clin Pharmacol 2002; 24: 357-359
90. Christina AJ, Packia Lakshmi M, Nagarajan M, Kurian S. Modulatory effect of Cyclea peltata Lam. on stone formation induced by ethylene glycol treatment in rats. Methods Find Exp Clin Pharmacol 2002; 24: 77-79
91. Anand R, Patnaik GK, Kulshreshtha DK, Dhawan BN. Activity of certain fractions of Tribulus terrestris fruits against experimentally induced urolithiasis in rats. Indian J Exp Biol 1994; 32: 548-552
92. Poonguzhali PK, Chegu H. The influence of banana stem extract on urinary risk factors for stones in normal and hyperoxaluric rats. Br J Urol 1994; 74: 23-25
93. Prasad KV, Bharathi K, Srinivasan KK. Evaluation of Ammannia baccifera Linn. for antiurolithic activity in albino rats. Indian J Exp Biol 1994; 32: 311-313
94. Joyamma V, Rao SG, Hrishikeshavan HJ, Aroor AR, Kulkarni DR. Biochemical mechanisms and effects of Mimosa pudica (Linn) on experimental urolithiasis in rats. Indian J Exp Biol 1990; 28: 237-240
95. Varalakshmi P, Shamila Y, Latha E. Effect of Crataeva nurvala in experimental urolithiasis. J Ethnopharmacol 1990; 28: 313-321
96. Hirayama H,Wang Z, Nishi K, Ogawa A, Ishimatu T, Ueda S, Kubo T, Nohara T. Effect of Desmodium styracifolium-triterpenoid on calcium oxalate renal stones. Br J Urol 1993; 71: 143-147
97. Ogawa Y, Takahashi S, Kitagawa R. Effect of herb medicines for urolithiasis on urinary oxalate excretion in rats. Hinyokika Kiyo 1983; 29: 1269-1271
98. Araujo Viel T, Diogo Domingos C, da Silva Monteiro AP, Riggio Lima- Landman MT, Lapa AJ, Souccar C. Evaluation of the antiurolithiatic activity of the extract of Costus spiralis Roscoe in rats. J Ethnopharmacol 1999; 66: 193-198
99. Tsai CH, Chen YC, Chen LD, Pan TC, Ho CY, Lai MT, Tsai FJ, Chen WC. A traditional Chinese herbal antilithic formula, Wulingsan, effectively prevents the renal deposition of calcium oxalate crystal in ethylene glycol-fed rats. Urol Res 2008; 36: 17-24
100. Xue JZ. A preliminary laboratory investigation of "niao shi mixture" in preventing experimental calcium oxalate renal calculus in rats. J Tradit Chin Med 1982; 2: 187-194
101. Vargas Solis R, Perez Gutierrez RM. Diuretic and urolithiatic activities of the aqueous extract of the fruit of Randia echinocarpa on rats. J Ethnopharmacol 2002; 83: 145-147
102. Vargas R, Perez RM, Perez S, Zavala MA, Perez C. Antiurolithiatic activity of Raphanus sativus aqueous extract on rats. J Ethnopharmacol 1999; 68: 335-338
103. Laroubi A, Touhami M, Farouk L, Zrara I, Aboufatima R, Benharref A, Chait A. Prophylaxis effect of Trigonella foenum graecum L. seeds on renal stone formation in rats. Phytother Res 2007; 21: 921-925
104. Hadjzadeh MA, Khoei A, Hadjzadeh Z, Parizady M. Ethanolic extract of Nigella sativa L. seeds on ethylene glycol-induced kidney calculi in rats. Urol J 2007; 4: 86-90
105. Schneider HJ, Unger G, Rossler D, Bothor C, Berg W, Ernst G. Effect of drugs used for the prevention of urinary calculi recurrence on the growth andmetabolism of young experimental animals. Z Urol Nephrol 1979; 72: 237-247